Humorvoll intellektuell weil hla e Die Form Ein Bild malen Idol
PE Mouse Anti-Human HLA-E
HLA-E restricted responses in Tuberculosis
All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric Peptide | Journal of Chemical Information and Modeling
Technology | Universal Cells
HLA-E - Wikipedia
Human class I HLA-E Tetramer | MBLライフサイエンス
Harnessing HLA‐E‐restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID‐19 - Caccamo - 2020 - British Journal of Haematology - Wiley Online Library
Human class I HLA-E Tetramer | MBL Life Sience -ASIA-
Immunological mechanisms of HLa-e-mediated immunosuppression by cancer... | Download Scientific Diagram
Immunobiology of HLA Class-Ib Molecules in Transplantation
HLA-E: A Novel Player for Histocompatibility
Natural killer cell receptors regulate responses of HLA-E–restricted T cells | Science Immunology
Vaccines | Free Full-Text | Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity | Communications Biology
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells - ScienceDirect
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A | PNAS
Cytotoxic Lymphocyte Recognition of HLA-E: Immunity
Current status and future perspectives of HLA-edited induced pluripotent stem cells | Inflammation and Regeneration | Full Text
HLA Class I Histocompatibility Antigen, Alpha Chain E | SpringerLink
Frontiers | HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?
HLA‐E: exploiting pathogen‐host interactions for vaccine development - Sharpe - 2019 - Clinical & Experimental Immunology - Wiley Online Library
Frontiers | Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions
Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantat